2GM9 | pdb_00002gm9

Structure of rabbit muscle glycogen phosphorylase in complex with thienopyrrole


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.245 (Depositor), 0.261 (DCC) 
  • R-Value Work: 
    0.182 (Depositor) 
  • R-Value Observed: 
    0.186 (Depositor) 

Starting Model: other
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 2GM9

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.

Whittamore, P.R.Addie, M.S.Bennett, S.N.Birch, A.M.Butters, M.Godfrey, L.Kenny, P.W.Morley, A.D.Murray, P.M.Oikonomakos, N.G.Otterbein, L.R.Pannifer, A.D.Parker, J.S.Readman, K.Siedlecki, P.S.Schofield, P.Stocker, A.Taylor, M.J.Townsend, L.A.Whalley, D.P.Whitehouse, J.

(2006) Bioorg Med Chem Lett 16: 5567-5571

  • DOI: https://doi.org/10.1016/j.bmcl.2006.08.047
  • Primary Citation Related Structures: 
    2GJ4, 2GM9

  • PubMed Abstract: 

    Two series of novel thienopyrrole inhibitors of recombinant human liver glycogen phosphorylase a (GPa) which are effective in reducing glucose output from rat hepatocytes are described. Representative compounds have been shown to bind at the dimer interface site of the rabbit muscle enzyme by X-ray crystallography.


  • Organizational Affiliation
    • AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. paul.whittamore@astrazeneca.com

Macromolecule Content 

  • Total Structure Weight: 95.86 kDa 
  • Atom Count: 7,052 
  • Modeled Residue Count: 805 
  • Deposited Residue Count: 825 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Glycogen phosphorylase, muscle form825Oryctolagus cuniculusMutation(s): 0 
EC: 2.4.1.1
UniProt
Find proteins for P00489 (Oryctolagus cuniculus)
Explore P00489 
Go to UniProtKB:  P00489
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00489
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
3TH

Query on 3TH



Download:Ideal Coordinates CCD File
C [auth A]2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
C16 H12 Cl N3 O2 S
LJAHIGGEXIWVJG-LLVKDONJSA-N
PLR

Query on PLR



Download:Ideal Coordinates CCD File
B [auth A](5-HYDROXY-4,6-DIMETHYLPYRIDIN-3-YL)METHYL DIHYDROGEN PHOSPHATE
C8 H12 N O5 P
RBCOYOYDYNXAFA-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.245 (Depositor), 0.261 (DCC) 
  • R-Value Work:  0.182 (Depositor) 
  • R-Value Observed: 0.186 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 126.781α = 90
b = 126.781β = 90
c = 115.144γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
ADSCdata collection
MOSFLMdata reduction
AMoREphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2007-02-13
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Advisory, Derived calculations, Version format compliance
  • Version 1.3: 2024-02-14
    Changes: Data collection, Database references, Derived calculations
  • Version 1.4: 2024-04-03
    Changes: Refinement description